REG - Ebiquity PLC - Issue of Shares

EbiquityAnnouncement

06/07/2018 15:05

RNS Number : 9116T
Ebiquity PLC
06 July 2018
 


 
Ebiquity Plc
("the Company")
 
Issue of Shares
 
Ebiquity plc announces it has issued 93,730 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of options under the Company's share option schemes.
 
Application has been made for the new Ordinary Shares to be admitted to AIM, with an admission date expected to be 12 July 2018.  Upon admission, the shares will rank parri passu in all respects with the existing Ordinary Shares of the Company.
 
Following the anticipated admission of these shares, the total number of ordinary shares in issue will be 78,531,420 with each share carrying the right to one vote. The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Ordinary Shares to satisfy certain awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Ordinary Shares held by it. As such 4,200,000 Ordinary Shares are treated as not carrying voting rights. The figure of 74,331,420 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.
 
06 July 2018
 



Enquiries:
Ebiquity plc
Michael Karg (CEO)
Mark Sanford (Company Secretary)
 
Instinctif Partners
Matthew Smallwood
Guy Scarborough
 


 
 
 
020 7650 9600
 
 
 
020 7457 2020




Numis Securities Limited
Nick Westlake    Oliver Hardy (NOMAD)
Toby Adcock (Corporate Broker)


 
 
020 7260 1000



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUGUQAMUPRGWQ